You are here

Subscribe

Donors Your Gifts at Work

All
All

We invite you to share your story to help raise awareness. If you have been or are being treated for cancer at Duke or if you are a caregiver, we'd like to know how cancer care, research or clinical trials at Duke has affected your life. Are you a donor? If so, please consider sharing you story. Tell us why you choose to team up with Duke Cancer Institute. For more information or to share your story, please contact Sara Wajda, Director of Annual Giving, DCI Development.

Fall 2018 Breakthroughs Message From The Director

At Duke Cancer Institute, inspired by the bravery of our patients, we don’t shrink from even the most daunting challenges. We tackle them head-on.

Stopping A Stealth Disease

Survivors, family members, and researchers have been working together for more than a decade to detect ovarian cancer earlier and educate women about its signs.

Emerging Options For Gynecologic Cancers

Women with gynecological cancer have more treatment options than ever. Currently, Duke has 15 clinical trials open for women with gynecologic cancers, including ovarian, endometrial, or cervical cancer.

In The Genes

You learn you have a genetic history of cancer. Now what? Noah Kauff, MD, is at the forefront of answering that question, especially for women's cancers.

Guaging Risk

Led by breast surgeon and Assistant Professor of Surgery Jennifer Plichta, MD, MS, Duke’s Breast Risk Assessment Clinic helps women learn about their individual likelihood for developing the disease.

Machine Learning

For women with ductal carcinoma in situ, Duke researchers are working to use “machine learning” to reduce unnecessary follow-up breast imaging and offer some women less-invasive treatment options.

Fighting Melanoma With Team Tom

It would be hard to find a more affable person than longtime Durham resident Tom Drew. Even as he is being treated for advanced melanoma, he is determined to find humor and make new friends.

Blurring the Racial Lines on Prostate Cancer

An increased survival benefit for black men with advanced prostate cancer and a stronger response to hormone therapy were the centerpieces of racial disparity studies presented by researchers from Duke’s Prostate & Urologic Cancer Center.

Susan Dent Joins DCI to Co-lead Cardio-Oncology

Susan Dent, MD, FRCPC, joined Duke Cancer Institute in September 2018 to co-lead Duke’s efforts in cardio-oncology—a discipline focused on the intersection of heart disease and cancer. She'll also serve as professor of medicine and associate director of breast cancer clinical research.

Pages